Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens Mubadala's ...

A significant legal dispute has emerged between Abu Dhabi's Mubadala investment Company and Getir's founders, centering on control of the Turkish rapid delivery service. Founder Nazım Salur has ...

Mubadala Investment Company, Abu Dhabi’s state-owned investment fund, is making strides in integrating artificial intelligence into its decision-making processes. The firm has announced plans to ...

A significant legal dispute has emerged between Abu Dhabi’s Mubadala Investment Company and Getir’s founders, centering on control of the Turkish rapid delivery service. Founder Nazım Salur has ...

DiabTec’s facility includes 20,000-liter drug substance reactors and a separate cartridge fill-finish facility for drug products KELIX bio, wholly owned by Mubadala Investment Company (Mubadala), said ...

KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens ...

UAE - Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens ...

It also complements KELIX bio’s recent acquisition of four GlobalOne Healthcare Holding assets. About Mubadala Investment Company Mubadala Investment Company is a sovereign investor managing a global ...

Mubadala Investment Company has released its 2022 financial results for the Group.Despite a challenging macroeconomic environment in 2022 that significantly impacted financial markets and investor ...